《MedRxiv,3月6日,The potential role of IL-6 in monitoring coronavirus disease 2019.》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-07
  • The potential role of IL-6 in monitoring coronavirus disease 2019.

    Tao Liu, Jieying Zhang, Yuhui Yang, Liling Zhang, Hong Ma, Zhengyu Li, Jiaoyue Zhang, Ji Cheng, Xiaoyu Zhang, Gang Wu, Jianhua Yi

    doi: https://doi.org/10.1101/2020.03.01.20029769

    Abstract

    Abstract. Background: The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan City, China spreads rapidly since December, 2019. Most patients show mild symptoms, but some of them develop into severe disease. There is currently no specific medication. The purpose of this study is to explore changes of markers in peripheral blood of severe COVID-19 patients, which may be of value in disease monitoring. Methods: Clinical data of patients with nonsevere and severe type COVID-19 diagnosed by laboratory test in our institution were collected.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.medrxiv.org/content/10.1101/2020.03.01.20029769v1
相关报告
  • 《MedRxiv,3月6日,Immunodepletion with Hypoxemia: A Potential High Risk Subtype of Coronavirus Disease 2019》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-07
    • Immunodepletion with Hypoxemia: A Potential High Risk Subtype of Coronavirus Disease 2019 Lilei Yu, Yongqing Tong, Gaigai Shen, Aisi Fu, Yanqiu Lai, Xiaoya Zhou, Yuan Yuan, Yuhong Wang, Yuchen Pan, Zhiyao Yu, Yan Li, Tiangang Liu, Hong Jiang doi: https://doi.org/10.1101/2020.03.03.20030650 Abstract Background The outbreak of COVID-2019 is becoming a global public health emergency. Although its basic clinical features have been reported, the dynamic characteristics of immune system in COVID-2019 patients, especially those critical patients with refractory hypoxemia, are not yet well understood. We aim to describe the dynamic characteristics of immune system in 3 critical patients with refractory hypoxemia, and discuss the relationship between hypoxemia severity and immune cell levels, and the changes of gut microbes of COVID-2019 patient. Methods This is a retrospective study from 3 patients with 2019-nCoV infection admitted to Renmin Hospital of Wuhan University, a COVID-2019 designated hospital in Wuhan, from January 31 to February 6, 2020. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《MedRxiv,3月16日,Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-17
    • Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China Yaling Shi, Mingkai Tan, Xing Chen, Yanxia Liu, Jide Huang, Jingyi Ou, Xilong Deng doi: https://doi.org/10.1101/2020.03.12.20034736 Abstract Coronavirus disease 2019 (COVID-19) is a respiratory disorder caused by the highly contagious SARS-CoV-2. The immunopathological characteristics of COVID-19 patients, either systemic or local, have not been thoroughly studied. In the present study, we analyzed both the changes in the cellularity of various immune cell types as well as cytokines important for immune reactions and inflammation. Our data indicate that patients with severe COVID-19 exhibited an overall decline of lymphocytes including CD4+ and CD8+ T cells, B cells, and NK cells. The number of immunosuppressive regulatory T cells was moderately increased in patients with mild COVID-19. IL-2, IL-6, and IL-10 were remarkably up-regulated in patients with severe COVID-19. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.